Fresenius Medical Care AG (FMS) Equity Income (2010 - 2025)

Fresenius Medical Care AG (FMS) has reported Equity Income for 16 consecutive years, with -$48.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Equity Income fell 42.97% year-over-year to -$48.9 million; the TTM figure through Dec 2025 stood at -$204.7 million (down 39.86% YoY), while the FY2025 annual figure was -$210.7 million, down 46.05% from the prior year.
• Equity Income came in at -$48.9 million for Q4 2025 at Fresenius Medical Care AG, up from -$54.6 million in the prior quarter.
• The five-year high for Equity Income was -$11.8 million in Q1 2022, with the low at -$54.6 million in Q3 2025.
• Average Equity Income over 5 years is -$33.1 million, with a median of -$30.4 million recorded in 2023.
• Across the five-year window, Equity Income slumped 527.78% in 2021 and jumped 65.15% in 2022, its largest moves.
• Year by year, Equity Income stood at -$24.0 million in 2021, then rose by 19.31% to -$19.4 million in 2022, then retreated by 27.66% to -$24.7 million in 2023, then slumped by 38.18% to -$34.2 million in 2024, then sank by 42.97% to -$48.9 million in 2025.
• According to Business Quant data, Equity Income over the past three periods registered -$48.9 million, -$54.6 million, and -$50.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.